Hannah Joseph Hospital
add_icon

Hannah Joseph Hospital

109.85
-1.15
(-1.04%)
Market Cap
249.29 Cr
PE Ratio
-
Volume
10,000.00
Day High - Low
111.50 - 109.65
52W High-Low
128.80 - 55.99
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
249.29 Cr
EPS
6.32
PE Ratio
-
PB Ratio
-
Book Value
42.90
EBITDA
25.70
Dividend Yield
0.00 %
Industry
Healthcare
Sector
Hospital
Return on Equity
11.48
Debt to Equity
0.43
Forecast For
Actual

Company News

View All News
Caret
positive
Hannah Joseph Hospital reported FY26 revenue of ₹92.05 Cr, with PAT rising to ₹11.18 Cr. The company highlighted its focus on neurosciences and trauma care.
neutral
Hannah Joseph Hospital Ltd scheduled its 15th AGM for July 15, 2026, to consider a final dividend of ₹2 per share for FY26. The record date for dividend eligibility is July 8, 2026.
positive
Hannah Joseph Hospital reported a 55% rise in net profit to ₹1,118.12 lakh for FY26. The Board recommended a final dividend of ₹2 per share.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
109.85
#1 249.29
#1 -
#1 92.60
#1 18.87
#1 11
-
57.56
Growth Rate
Revenue Growth
18.87 %
Net Income Growth
55.56 %
Cash Flow Change
6.49 %
ROE
-17.29 %
ROCE
-7.95 %
EBITDA Margin (Avg.)
2.74 %

Yearly Financial Results

Annual Financials
2021
2022
2023
2024
2025
2026
TTM
Revenue
38
58
55
64
78
93
0
Expenses
28
40
38
45
57
67
0
EBITDA
10
18
17
18
21
26
0
Operating Profit %
21 %
31 %
30 %
29 %
27 %
27 %
0 %
Depreciation
7
11
9
8
7
7
0
Interest
5
7
6
5
4
3
0
Profit Before Tax
-3
0
1
5
10
16
0
Tax
0
0
0
1
3
5
0
Net Profit
-3
0
1
4
7
11
0
EPS in ₹
-13.86
0.86
0.63
2.44
4.32
6.32
0.00

Balance Sheet

Balance Sheet
2021
2022
2023
2024
2025
2026
Total Assets
94
86
92
90
97
133
Fixed Assets
86
77
71
65
69
73
Current Assets
4
5
15
20
20
50
Capital Work in Progress
0
0
0
0
1
5
Investments
0
0
0
0
0
0
Other Assets
8
10
21
25
27
55
Total Equity & Liabilities
94
86
92
90
97
133
Current Liabilities
11
9
20
13
15
11
Non Current Liabilities
58
53
37
31
30
25
Total Equity
24
25
35
46
52
97
Reserve & Surplus
23
14
18
29
35
75
Share Capital
2
11
16
17
17
23

Cash Flow

Cash Flow
2021
2022
2023
2024
2025
2026
Net Cash Flow
1
1
5
2
3
-3
Investing Activities
-8
-0
-5
-4
-14
-49
Operating Activities
7
15
21
8
19
21
Financing Activities
2
-14
-10
-3
-3
25

Share Holding

% Holding
Mar 2025
Jan 2026
Feb 2026
Mar 2026
Promoter
93.57 %
93.57 %
68.83 %
71.28 %
FIIs
0.00 %
0.00 %
2.39 %
0.56 %
DIIs
0.00 %
0.00 %
10.15 %
9.05 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
0.00 %
15.79 %
12.20 %
Others
6.43 %
6.43 %
2.84 %
6.91 %
No of Share Holders
36
37
628
376

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
15 Jul 2026 ANNUAL GENERAL MEETING Annual General Meeting
NA
15 Jul 2026 94.12 111.00
29 May 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
29 May 2026 75.00 72.01
08 Jul 2026 DIVIDEND Dividend
2.00 /share
08 Jul 2026 72.01 118.00

Announcements

Announcement under Regulation 30 (LODR)-Press Release / Media Release5 days ago
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 201810 days ago
Announcement under Regulation 30 (LODR)-Newspaper PublicationJun 19, 2026
Reg. 34 (1) Annual Report.Jun 18, 2026
Notice Of 15Th Annual General Meeting Of The Company Scheduled To Be Held On July 15 2026Jun 16, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationJun 16, 2026
Intimation Of Cut-Off Date And Remote E-Voting Schedule For The 15Th Annual General MeetingJun 15, 2026
Intimation Of Record Date For Final Dividend For The Financial Year 2025-26Jun 15, 2026
Intimation Of 15Th Annual General Meeting Of The Company Scheduled To Be Held On 15.07.2026Jun 15, 2026
Corporate Action-Board approves DividendMay 29, 2026
Announcement under Regulation 30 (LODR)-Change in ManagementMay 29, 2026
Statement On Deviation Or Variation For Proceeds Of Public IssueMay 29, 2026
Audited Financial Results For The Half Year And Year Ended March 31 2026.May 29, 2026
Board Meeting Outcome for Approval Of Audited Financial Results For The Half Year And Financial Year Ended 31St March 2026 And Recommendation Of Final Dividend For The Financial Year 2025-26May 29, 2026
Update on board meetingMay 21, 2026
Board Meeting Intimation for Board Meeting Intimation For Approving The Audited Financial Results For The Half Year And Year Ended March 31 2026.May 18, 2026
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 27, 2026
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Apr 22, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 09, 2026
Intimation Of Disclosure Under Regulation 7(2)(B) Of The SEBI (Prohibition Of Insider Trading) Regulations 2015Apr 06, 2026
Disclosure Under Regulation 31(4) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations 2011Apr 03, 2026
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Apr 01, 2026
Intimation Of Disclosure Under Regulation 7(2)(B) Of The SEBI (Prohibition Of Insider Trading) Regulations 2015Mar 31, 2026
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 30, 2026
Intimation Of Disclosure Under Regulation 7(2)(B) Of The SEBI (Prohibition Of Insider Trading) Regulations 2015Mar 28, 2026
Closure of Trading WindowMar 24, 2026
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 20, 2026
Intimation Of Disclosure Under Regulation 7(2)(B) Of The SEBI (Prohibition Of Insider Trading) Regulations 2015Mar 20, 2026
Intimation Of Change In Corporate Identification Number (CIN) Pursuant To Listing Of Equity SharesMar 11, 2026
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Mar 09, 2026
Announcement under Regulation 30 (LODR)-Change in RTAMar 07, 2026
Intimation Under Regulation 6(1) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Mar 07, 2026
Intimation Under Regulation 8(2) Of The Securities Exchange Board Of India (Prohibition Of Insider Trading) Regulations 2015Mar 06, 2026
Intimation Under Regulation 30 Of SEBI (LODR) Regulations 2015 - Appointment Of Investor Relation Agency.Mar 06, 2026
Intimation Under Regulation 30(5) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements Regulations) 2015Mar 06, 2026
Intimation Under Regulation 30 Of SEBI (LODR) Regulations 2015 - Acquisition Of LandMar 05, 2026
Intimation Under Regulation 30 Of SEBI (LODR) Regulations 2015 - Receipt Of AwardMar 04, 2026
Listing of Equity Shares of Hannah Joseph Hospital LtdFeb 02, 2026

Technical Indicators

RSI(14)
Neutral
57.56
ATR(14)
Volatile
5.39
STOCH(9,6)
Neutral
48.94
STOCH RSI(14)
Oversold
10.90
MACD(12,26)
Bearish
-0.65
ADX(14)
Strong Trend
35.09
UO(9)
Bearish
48.80
ROC(12)
Uptrend And Accelerating
12.12
WillR(14)
Neutral
-53.45